Related Experiment Videos
Does altered glucocorticoid homeostasis increase cardiovascular risk?
John P Girod1, Daniel J Brotman
1Hospital Medicine Fellowship, Department of General Internal Medicine/S70, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Cardiovascular Research
|October 16, 2004
Summary
The hypothalamic-pituitary-adrenal (HPA) axis, crucial for stress response, may contribute to cardiovascular disease through chronic glucocorticoid exposure. Indirect evidence suggests HPA axis dysregulation increases cardiovascular risk, particularly in conditions like depression and inflammatory diseases.
Area of Science:
- Endocrinology
- Cardiovascular Science
- Stress Physiology
Background:
- The hypothalamic-pituitary-adrenal (HPA) axis is vital for life-sustaining stress responses, modulating vascular tone, fuel availability, inflammation, and tissue repair.
- Chronic activation of stress systems, including the sympathetic nervous system and renin-angiotensin-aldosterone (RAA) system, has known detrimental cardiovascular effects.
- Prolonged exposure to glucocorticoids, regulated by the HPA axis, can induce metabolic and vascular changes, accelerating vascular senescence.
Purpose of the Study:
- To explore the indirect relationship between chronic activation of the HPA axis and cardiovascular disease (CVD).
- To investigate the potential cardiovascular risks associated with glucocorticoid effects in conditions characterized by chronic HPA axis activation.
Main Methods:
- Review of studies on the cardiovascular effects of exogenous glucocorticoids.
- Analysis of studies examining individual variations in endogenous glucocorticoid activity.
- Synthesis of indirect evidence due to the lack of direct clinical studies linking the HPA axis and CVD.
Main Results:
- Exogenous glucocorticoids can induce metabolic and vascular changes, offering insights into potential endogenous glucocorticoid effects.
- Individual differences in endogenous glucocorticoid activity suggest varying susceptibility to HPA axis-related cardiovascular risks.
- Chronic HPA axis activation, seen in major depression and inflammatory diseases, is hypothesized to contribute to CVD risk via glucocorticoid effects.
Conclusions:
- Chronic HPA axis activation may represent a significant, albeit indirectly evidenced, contributor to cardiovascular disease.
- Understanding the impact of endogenous glucocorticoids is crucial for assessing the full spectrum of HPA axis-related CVD risks.
- Further direct clinical research is needed to definitively establish the HPA axis-CVD link.